Skip to content

S. 2121 · 119th Congress (2025–2027)

SUPPORT for Patients and Communities Reauthorization Act of 2025

This bill reauthorizes and revises Department of Health and Human Services (HHS) programs that address substance use disorders, overdoses, and mental health.

For example, the bill reauthorizes for FY2026-FY2030 grant and other programs relating to

• addressing substance use disorders with respect to pregnant and postpartum women,
• prevention and recovery from substance use disorders for youth,
• housing for individuals in recovery from substance use disorders,
• community organizations facilitating recovery from substance use disorders,
• loan repayment for certain health care providers treating substance use disorders,
• prevention of overdoses of controlled substances,
• treatment of children experiencing psychological trauma, and
• mental and behavioral health education and training for medical and allied health students.

Also, the bill revises several programs, including by (1) expanding a program that supports resources for first responders to include the purchase of drugs or devices to treat non-opioid overdoses, (2) expanding a program that supports employment services for individuals in recovery so as to allow for the provision of related transportation services, and (3) temporarily authorizing a regional technical assistance center to assist the National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support.

Additionally, the bill establishes new requirements for HHS, including requirements relating to

• protecting the National Suicide Prevention Lifeline program from cybersecurity threats,
• establishing a Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs, and
• reviewing and potentially revising the scheduling of approved products containing a combination of buprenorphine and naloxone under the Controlled Substances Act.

Show official title

A bill to reauthorize certain programs that provide for opioid use disorder prevention, treatment, and recovery, and for other purposes.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is S. 2121’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

Sponsor
Sen. Bill Cassidy (R-LA)
Cosponsors
8 cosponsors

7 original · 1 later

4 R · 3 D · 1 I

  1. Sen. Tammy Baldwin (D-WI)· Original · Jun 18, 2025
  2. Sen. John W. Hickenlooper (D-CO)· Original · Jun 18, 2025
  3. Sen. Margaret Wood Hassan (D-NH)· Original · Jun 18, 2025
  4. Sen. Lisa Murkowski (R-AK)· Original · Jun 18, 2025
  5. Sen. Markwayne Mullin (R-OK)· Original · Jun 18, 2025
  6. Sen. Bernard Sanders (I-VT)· Original · Jun 18, 2025
  7. Sen. Tommy Tuberville (R-AL)· Original · Jun 18, 2025
  8. Sen. Jon Husted (R-OH)· Later · Jul 16, 2025
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest

    Referred to committee

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Sources

Committees

  1. SenateHealth, Education, Labor, and PensionsReferred Jun 18, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Titles (2)
  1. SUPPORT for Patients and Communities Reauthorization Act of 2025

    Display title, Short title · Introduced in Senate

  2. A bill to reauthorize certain programs that provide for opioid use disorder prevention, treatment, and recovery, and for other purposes.

    Official title · Introduced in Senate